Key Ratios
Checked just nowMarket Cap₹28,307 Cr
Current Price₹8,720.5
Previous Close₹8,781.97
High / Low (52w)₹14,540 / ₹8,688
Volume21,903
Avg Vol (1W)7,447
Avg Vol (1M)5,503
Stock P/E33.05
Book Value₹232.12
Dividend Yield2.9%
ROE113.67%
ROA47.49%
Revenue (TTM)₹4,290 Cr
Revenue Growth—
Profit Margin20%
Total Debt—
Shares Outstanding3 Cr
Face Value₹10
EPS (TTM)₹263.86
P/B37.57
Debt / Equity0
50 DMA₹8,957.93
200 DMA₹9,802.18
Day change-0.70%
Price Chart
₹8,720.5▼ 31.97% · 1Y
2025-11-242026-07-17
20-day avg volume: 5K shares
Pros
- Healthy return on equity of 113.7%.
- Pays a dividend yield of 2.9%.
- Company is almost debt-free.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹932 Cr | ₹1,135 Cr | ₹1,248 Cr | ₹992 Cr | ₹937 Cr | ₹1,150 Cr | ₹1,262 Cr | ₹941 Cr |
| EBITDA | ₹112 Cr | ₹287 Cr | ₹371 Cr | ₹218 Cr | ₹265 Cr | ₹285 Cr | ₹405 Cr | ₹221 Cr |
| Net Profit | ₹81 Cr | ₹212 Cr | ₹269 Cr | ₹156 Cr | ₹192 Cr | ₹210 Cr | ₹301 Cr | ₹153 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025 | Jun 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹3,046 Cr | ₹3,614 Cr | ₹3,925 Cr | ₹3,958 Cr | ₹4,258 Cr | ₹3,412 Cr | ₹4,311 Cr | ₹4,290 Cr |
| EBITDA | ₹600 Cr | ₹876 Cr | ₹801 Cr | ₹851 Cr | ₹966 Cr | ₹876 Cr | ₹0 Cr | ₹0 Cr |
| Net Profit | ₹433 Cr | ₹652 Cr | ₹576 Cr | ₹678 Cr | ₹675 Cr | ₹637 Cr | ₹829 Cr | ₹857 Cr |
| EPS | 133.42 | 200.79 | 177.37 | 208.91 | 207.95 | 196.11 | — | — |
Balance Sheet
| Metric | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹1,617 Cr | ₹1,828 Cr | ₹1,633 Cr | ₹1,683 Cr | ₹2,137 Cr | ₹1,859 Cr | ₹1,755 Cr | ₹1,804 Cr |
| Total Liabilities | ₹708 Cr | ₹671 Cr | ₹918 Cr | ₹945 Cr | ₹1,191 Cr | ₹1,084 Cr | ₹1,018 Cr | ₹1,050 Cr |
| Equity | ₹909 Cr | ₹1,158 Cr | ₹714 Cr | ₹738 Cr | ₹946 Cr | ₹775 Cr | ₹737 Cr | ₹753 Cr |
| Total Debt | — | — | — | — | — | — | — | ₹87,00,000 Cr |
Cash Flow
| Metric | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Operating | ₹1,117 Cr | ₹822 Cr | ₹1,055 Cr | ₹768 Cr | ₹836 Cr | ₹924 Cr |
| Investing | ₹7 Cr | ₹-27 Cr | ₹-10 Cr | ₹1 Cr | ₹-34 Cr | ₹11 Cr |
| Financing | ₹-1,106 Cr | ₹-569 Cr | ₹-477 Cr | ₹-861 Cr | ₹-666 Cr | ₹-845 Cr |
| Free Cash Flow | ₹1,117 Cr | ₹822 Cr | ₹1,055 Cr | ₹768 Cr | ₹836 Cr | ₹875 Cr |
Shareholding
Promoter 70.64% Institutions 16.93% Public 12.43%
About P&G Hygiene & Health Care
Consumer Defensive · Household & Personal Products
Procter & Gamble Hygiene and Health Care Limited manufactures and sells branded packaged fast-moving consumer goods in the feminine care and healthcare businesses in India and internationally. It operates through Health care Products and Hygiene Products segments. The company offers health care products, including ointments and creams, cough drops, and tablets; and hygiene products, such as feminine hygiene and other skin care hygiene products, as well as feminine care pads. It also provides baby care products comprising nappies, pants, and baby wipes; grooming products; laundry products; hair care products; home, personal and skin care, and oral products. The company sells its products under the Vicks, Whisper, Pampers, Ariel, Tide, Gillette, Head & Shoulders, Herbal Essences, Pantene, Ambi Pur, Oral-B, Olay, and Old Spice brands through mass merchandisers, as well as grocery, membership club, drug, department, and high frequency stores. The company was incorporated in 1964 and is based in Mumbai, India. Procter & Gamble Hygiene and Health Care Limited operates as a subsidiary of The Procter & Gamble Company.
in.pg.com ↗Efficiency & Working Capital
ROCE155.9%
Interest Coverage61.3
Dividend Payout—
Debtor Days33 d
Inventory Days24 d
Payable Days88 d
Cash Conversion Cycle-31 d
Working Capital Days57 d
Shareholding Details
As of 2026-03-31
Promoter70.6%
FII1%
DII16%
Institutions16.9%
Public12.4%
Promoter Pledge0%
No. of Shareholders53,416
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 70.6% | 70.6% | 70.6% | 70.6% | 70.6% | 70.6% | 70.6% | 70.6% | 70.6% | 70.6% | 70.6% | 70.6% |
| FIIs | 1.1% | 1.3% | 1.5% | 1.6% | 1.6% | 1.5% | 1.4% | 1.3% | 1.4% | 1.1% | 1.1% | 1% |
| DIIs | 15.4% | 15.4% | 15.3% | 15.1% | 15.2% | 15.3% | 15.4% | 15.5% | 15.5% | 16.1% | 16% | 16% |
| Public | 12.8% | 12.6% | 12.6% | 12.7% | 12.6% | 12.6% | 12.6% | 12.5% | 12.5% | 12.2% | 12.3% | 12.4% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 39,388 | 37,069 | 38,807 | 39,999 | 40,671 | 42,348 | 42,941 | 44,877 | 47,891 | 49,997 | 50,969 | 53,416 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Procter And Gamble Overseas India B.v. | Shareholding of Promoter and Promoter Group | 68.7% | 2.23 Cr |
| Sbi Focused Fund | Public Shareholding | 5.1% | 16,41,000 |
| Life Insurance Corporation Of India | Public Shareholding | 4.1% | 13,20,395 |
| Temple Trees Impex And Investment Private Limited | Shareholding of Promoter and Promoter Group | 1.9% | 6,19,683 |
| Icici Prudential Large Cap Fund | Public Shareholding | 1.8% | 5,83,781 |
| General Insurance Corporation Of India | Public Shareholding | 1.8% | 5,67,398 |
| Gillette India Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Gillette Diversified Operations Pvt. Ltd. | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Procter & Gamble Home Products Private Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Procter & Gamble Health Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| 1837, Llc | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Agile Pursuits Franchising, Inc. | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Agile Pursuits, Inc. | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Arbora & Ausonia, S.l.u. | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Braun (shanghai) Co., Ltd. | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Braun Gmbh | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Celtic Insurance Company, Inc. | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Detergent Products Sarl | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Detergenti S.a. | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Farmacy Beauty, Llc | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Farmacy Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Fater Central Europe Srl | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Fater Eastern Europe Llc | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Fater Portugal Unipessoal Lda | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Fater S.p.a. | Shareholding of Promoter and Promoter Group | 0% | 0 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Temple Trees Impex And Investment Private Limited | 0 | 0% | 2026-03-31 |
| Gillette India Limited | 0 | 0% | 2026-03-31 |
| Gillette Diversified Operations Pvt. Ltd. | 0 | 0% | 2026-03-31 |
| Procter & Gamble Home Products Private Limited | 0 | 0% | 2026-03-31 |
| Procter & Gamble Health Limited | 0 | 0% | 2026-03-31 |
| Procter And Gamble Overseas India B.v. | 0 | 0% | 2026-03-31 |
| 1837, Llc | 0 | 0% | 2026-03-31 |
| Agile Pursuits Franchising, Inc. | 0 | 0% | 2026-03-31 |
| Agile Pursuits, Inc. | 0 | 0% | 2026-03-31 |
| Arbora & Ausonia, S.l.u. | 0 | 0% | 2026-03-31 |
| Braun (shanghai) Co., Ltd. | 0 | 0% | 2026-03-31 |
| Braun Gmbh | 0 | 0% | 2026-03-31 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Chittranjan Dua | Chairman & Independent Directo | 2025 |
| Kumar Venkatasubramanian | Executive Director & MD | 2025 |
| Ghanashyam Hegde | ED / CS / CO / Head | 2025 |
| ASHIMA GOYAL | Independent Non Exe. Director | 2025 |
| Gurcharan Das. | Independent Non Exe. Director | 2025 |
| Krishnamurthy Narayanan Iyer | Independent Non Exe. Director | 2025 |
| P Agarwal | Non Executive Director | 2025 |
| Sonali Dhawan | Non Executive Director | 2025 |
| Srividya Srinivasan | Executive Director & CFO | 2025 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Health and Hygiene Product | ₹3,374 Cr | 100% |
Segments — Geography
| Region | Revenue | Share |
|---|---|---|
| India | ₹3,249 Cr | 96.3% |
| Outside India | ₹125 Cr | 3.7% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹10 | 35 | 32 | 32 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| forthcoming | 2026-07-29 | Board Meetings | — |
| dividend | 2026-02-05 | ₹25 (250%) | Special |
| dividend | 2026-02-05 | ₹170 (1700%) | Interim |
| dividend | 2025-08-28 | ₹65 (650%) | Final |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 1,073 | 0 | 0 | 5 | 25 | 1,820 |
| 2025 | 16 | 0 | 0 | 0 | 0 | 16 |
| 2025 | 0 | 0 | 0 | 0 | 0 | 161 |
Insider / Designated-Person Trades
2 recent disclosure(s)
Procter & Gamble Home Products Private LimitedAcquisition · 6,19,683
Temple Trees Impex and Investment Private LimitedDisposal · 6,19,683
Company Information
Incorporated1964
ChairmanChittranjan Dua
AuditorKalyaniwalla & Mistry LLP
Investor Email[email protected]; pginvestors@intimespectrum
📍 P & G Plaza Chakala, Cardinal Gracias Rd Andheri(E), Mumbai, Maharashtra, 400099
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search